Integrated Biopharma Inc Sample Contracts

AutoNDA by SimpleDocs
RECITALS
Asset Purchase Agreement • March 9th, 2007 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
ARTICLE I GENERAL
Agreement and Plan of Reorganization • March 13th, 2001 • Chem International Inc • Pharmaceutical preparations • New Jersey
RECITALS
Assignment and Assumption Agreement • August 6th, 2003 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
RECITALS
Settlement Agreement • December 23rd, 2004 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
WITNESSETH
Escrow Agreement • November 6th, 2003 • Integrated Biopharma Inc • Pharmaceutical preparations • Texas
ASSIGNMENT AGREEMENT
Assignment Agreement • August 6th, 2003 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
ARTICLE I THE MERGER
Agreement and Plan of Merger • February 24th, 2003 • Integrated Health Technologies Inc • Pharmaceutical preparations • New Jersey
ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE SELLER AS TO THE company
Purchase Agreement • February 26th, 2003 • Integrated Health Technologies Inc • Pharmaceutical preparations • New York
REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT PNC BANK, NATIONAL ASSOCIATION (AS LENDER AND AS AGENT) WITH INTEGRATED BIOPHARMA, INC., InB:MANHATTAN DRUG COMPANY, INC., AGROLABS, INC., IHT HEALTH PRODUCTS, INC., IHT PROPERTIES CORP. AND VITAMIN...
Security Agreement • June 29th, 2012 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

Revolving Credit, Term Loan and Security Agreement dated June 27, 2012 among INTEGRATED BIOPHARMA, INC., a corporation organized under the laws of the State of Delaware (“Integrated”), InB:MANHATTAN DRUG COMPANY, INC., a corporation organized under the laws of the State of New York (”MD”), AGROLABS, INC., a corporation organized under the laws of the State of New Jersey (“AL”), IHT HEALTH PRODUCTS, INC., a corporation organized under the laws of the State of Delaware (“IHT”), IHT PROPERTIES CORP., a corporation organized under the laws of the State of Delaware (“IHTP”), and VITAMIN FACTORY, INC. (also known as The Vitamin Factory), a corporation organized under the laws of the State of Delaware (“Vitamin”) (Integrated, MD, AL, IHT, IHTP and Vitamin, each a “Borrower”, and collectively “Borrowers”), the financial institutions which are now or which hereafter become a party hereto (collectively, the “Lenders” and individually a “Lender”) and PNC BANK, NATIONAL ASSOCIATION (“PNC”), as age

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 21st, 2004 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 19, 2004, by and among Integrated BioPharma, Inc., a Delaware corporation, with headquarters located at 225 Long Avenue, Hillside, New Jersey 07205 (the “Company”), and the undersigned buyers (each, a “Buyer” and collectively, the “Buyers”).

Exhibit 10.20 EXECUTION COPY INTEGRATED BIOPHARMA, INC. SUBSCRIPTION AGREEMENT
Subscription Agreement • September 29th, 2003 • Integrated Biopharma Inc • Pharmaceutical preparations • Delaware
AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 21st, 2004 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 19, 2004, by and among Integrated BioPharma, Inc., a Delaware corporation, with headquarters located at 225 Long Avenue, Hillside, New Jersey 07205 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS REGISTRATION RIGHTS AGREEMENT, dated as of October 14, 2008 (this “Agreement”), is by and between INTEGRATED BIOPHARMA, INC., a Delaware corporation (the “Company”), and each of the investors whose names appear on the signature pages hereof. Such investors are each referred to herein as an “Investor” and, collectively, as the “Investors”. The Company has agreed, on the terms and subject to the conditions set forth in the First Amendment to Amended and Restated Securities Purchase Agreement and 8% Senior Secured Notes, dated as of the date hereof (the “Amendment”), between the Company and the Investors, to issue to the Investors Warrants (the “Warrants”) exercisable for the Company’s Common Stock, par value $0.002 per share (the “Common Stock”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 22nd, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS SECURITIES PURCHASE AGREEMENT, dated as of February 21, 2008 (this “Agreement”), is by and between INTEGRATED BIOPHARMA, INC., a Delaware corporation (the “Company”), and IMPERIUM MASTER FUND, LTD., a Cayman Islands company (“Imperium”).

SECURITY AGREEMENT
Security Agreement • February 22nd, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS SECURITY AGREEMENT, dated as of February 21, 2008 (this “Agreement”), is by and among Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and each of the direct or indirect subsidiaries of the Company (whether now or hereafter existing, such subsidiaries, the “Subsidiaries” and, collectively with the Company, the “Debtors”), and Imperium Advisers, LLC, in its capacity as collateral agent (in such capacity, the “Collateral Agent”), for the benefit of Imperium Master Fund, Ltd. (“Imperium” and collectively with its successors and permitted assigns, the “Holders”), as holder of the 8% Senior Secured Note (as amended, restated, modified or supplemented from time to time, the “Note”) issued by the Company as of the date hereof, pursuant to the Securities Purchase Agreement, dated as of the date hereof (as amended, restated, modified or supplemented from time to time, the “Securities Purchase Agreement”), by and between the Company and Imperium. The Holders and the Colla

ARTICLE I THE PURCHASE AND SALE OF THE SECURITIES
Purchase Agreement • February 26th, 2003 • Integrated Health Technologies Inc • Pharmaceutical preparations • New York
SUBSIDIARY GUARANTEE
Subsidiary Guarantee • February 22nd, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS SUBSIDIARY GUARANTEE, dated as of February 21, 2008 (this “Guarantee”), is by and among each of the undersigned subsidiaries (together with any other entity that may become an additional guarantor hereunder, the “Guarantors”) of Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and CD Financial, LLC, in its capacity as collateral agent (in such capacity, the “Collateral Agent”), for the benefit of CD Financial, LLC (“Investor” and collectively with their permitted successors and assigns, the “Holders”) of the 9.5% Convertible Senior Secured Note (as amended, restated, supplemented or otherwise modified from time to time, the “Note”) issued as of the date hereof, pursuant to the Securities Purchase Agreement, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Securities Purchase Agreement”), by and between the Company and Investor. Capitalized terms used herein and not otherwise defined shall have the resp

CONTINUING LIMITED GUARANTY
Continuing Limited Guaranty • June 29th, 2012 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS CONTINUING LIMITED GUARANTY (this “Guaranty”) dated as of June 27, 2012 made by CARL DeSANTIS (the “Guarantor”), in favor of PNC BANK, NATIONAL ASSOCIATION, a National Banking Association organized under the laws of the United States of America, having an office located at PNC Bank Center, Two Tower Center Boulevard, East Brunswick, New Jersey 08816, as Agent for the Lenders, (the “Bank”).

IMPERIUM ADVISERS, LLC
Forbearance Agreement • January 26th, 2012 • Integrated Biopharma Inc • Pharmaceutical preparations

Reference is made to the Forbearance Agreement, dated as of October 4, 2011 (as amended, the “Forbearance Agreement”), by and between Integrated BioPharma, Inc. (the “Company”) and Imperium Advisers, LLC, in its capacity as collateral agent (in such “Collateral Agent”) for itself and the Investors referred to therein. Capitalized terms used and not otherwise defined in this letter shall have the meanings ascribed to them in the Forbearance Agreement.

FIFTH AMENDMENT TO REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • May 10th, 2024 • Integrated Biopharma Inc • Pharmaceutical preparations

THIS FIFTH AMENDMENT TO REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into May 9, 2024 by and among INTEGRATED BIOPHARMA, INC., a corporation organized under the laws of the State of Delaware (“Integrated”), MANHATTAN DRUG COMPANY, INC. (successor-by-merger to InB:MANHATTAN DRUG COMPANY, INC.), a corporation organized under the laws of the State of New Jersey (”MD”), AGROLABS, INC., a corporation organized under the laws of the State of New Jersey (“AL”), IHT HEALTH PRODUCTS, INC., a corporation organized under the laws of the State of Delaware (“IHT”), IHT PROPERTIES CORP., a corporation organized under the laws of the State of Delaware (“IHTP”), and VITAMIN FACTORY, INC. (also known as The Vitamin Factory), a corporation organized under the laws of the State of Delaware (“Vitamin”) (Integrated, MD, AL, IHT, IHTP and Vitamin, each a “Borrower”, and collectively “Borrowers”), the financial institutions which are now or which hereafter become a party h

FIRST AMENDMENT TO PROMISSORY NOTE
Promissory Note • February 19th, 2016 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

This FIRST AMENDMENT TO PROMISSORY NOTE, dated as of February 19, 2016 (this "Amendment"), among INTEGRATED BIOPHARMA, INC., a Delaware corporation (the "Company"), INB:MANHATTAN DRUG COMPANY, INC., a New York corporation ("MDC", and together with the Company, collectively, the "Loan Parties", and each, a "Loan Party"), and VITAMIN REALTY ASSOCIATES, LLC, a New Jersey limited liability company ("Vitamin").

REVOLVING CREDIT NOTE PNC Bank, National Association
Integrated Biopharma Inc • June 29th, 2012 • Pharmaceutical preparations • New York

This Revolving Credit Note (this “Note”) is executed and delivered under and pursuant to the terms of that certain Revolving Credit, Term Loan and Security Agreement dated as of the date hereof (as amended, restated, supplemented or modified from time to time, the “Loan Agreement”) by and among INTEGRATED BIOPHARMA, INC., a corporation organized under the laws of the State of Delaware (“Integrated”), InB:MANHATTAN DRUG COMPANY, INC., a corporation organized under the laws of the State of New York (”MD ”), AGROLABS, INC., a corporation organized under the laws of the State of New Jersey (“AL”), IHT HEALTH PRODUCTS, INC., a corporation organized under the laws of the State of Delaware (IHT”), VITAMIN FACTORY, INC., a corporation organized under the laws of the State of Delaware (“Vitamin”), IHT PROPERTIES CORP. a corporation organized under the laws of the State of Delaware (“IHTP”) (Integrated, MD, AL, IHT, Vitamin and IHTP each a “Borrower”, and collectively “Borrowers”), and PNC BANK,

THIRD AMENDMENT OF LEASE
Of Lease • September 13th, 2022 • Integrated Biopharma Inc • Pharmaceutical preparations

This THIRD AMENDMENT OF LEASE (this "Amendment") is made as of the 15th day of July 2022, between VITAMIN REALTY ASSOCIATES LLC (the LESSOR"), a New Jersey limited liability company, and MANHATTAN DRUG COMPANY, INC (the LESSEE"), a New Jersey corporation, having an address at 225 Long Avenue, Hillside, New Jersey 07205.

Mortgage and Security Agreement
Mortgage and Security Agreement • June 29th, 2012 • Integrated Biopharma Inc • Pharmaceutical preparations

THIS MORTGAGE AND SECURITY AGREEMENT (this “Mortgage”) is made as of the 27th day of June, 2012, by IHT PROPERTIES CORP., a Delaware corporation (the “Mortgagor”), with an address at 225 Long Avenue, Building 15, P.O. Box 278, Hillside, New Jersey 07205 in favor of PNC BANK, NATIONAL ASSOCIATION as Agent for the Lenders (the “Mortgagee”), with an address at Two Tower Center Boulevard, East Brunswick, New Jersey 08816.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!